Chemotherapy Versus Surgery in Primary B-Cell Lymphoma Masquerading as Klatskin Tumor—A Diagnostic and Therapeutic Dilemma
Authors:
- Abhimanyu GhoseAGAbhimanyu Ghose
- Namrata SethiNSNamrata Sethi
- Guiyuan LiGLGuiyuan Li
- Rekha ChaudharyRCRekha Chaudhary
- 1 November 2011
- journal article
- case report
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 18 (6) , e255-e257
Abstract
Primary lymphoma in the region of the liver bed mimicking hilar cholangiocarcinoma or Klatskin tumor is very rare. A patient presented with obstructive jaundice along with right upper quadrant pain, weight loss, and decreased appetite. Apart from altered liver function, her lactate dehydrogenase was significantly elevated, and imaging studies showed prominent lesion close to the liver bed with localized lymphadenopathy. The diagnosis ultimately reached at by biopsy and immunohistochemical staining was diffuse large B-cell lymphoma. Such cases are very infrequent, but demand awareness. The sooner the diagnosis can be reached by minimally invasive procedures, the earlier chemotherapy with rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone can be initiated and laparotomy can be avoided as chemotherapy is the mainstay of treatment, even in the presence of jaundice.Keywords
This publication has 13 references indexed in Scilit:
- Primary Biliary Lymphoma Mimicking Cholangiocarcinoma: A Characteristic Feature of Discrepant CT and Direct Cholangiography FindingsJournal of Korean Medical Science, 2009
- A Case of Primary Biliary Malignant Lymphoma Mimicking Klatskin TumorThe Korean Journal of Gastroenterology, 2009
- Primary non-Hodgkin’s lymphoma of the main hepatic duct junctionJournal of Hepato-Biliary-Pancreatic Surgery, 2008
- Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)The Lancet Oncology, 2008
- Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell LymphomaJournal of Clinical Oncology, 2006
- CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) GroupThe Lancet Oncology, 2006
- Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British ColumbiaJournal of Clinical Oncology, 2005
- Diffuse large B‐cell lymphoma: clinical implications of extranodal versus nodal presentation – a population‐based study of 1575 casesBritish Journal of Haematology, 2003
- Primary biliary malignant lymphoma clinically mimicking cholangiocarcinoma: A case report and review of the literatureAnnals of Diagnostic Pathology, 2001
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993